The area under the receiver-operator curve for this parameter alone was 0.69, and was 0.89 when other variables with P 0.10 in univariable analysis were included in the model. Conclusion. Low urinary PO 2 during adult cardiac surgery requiring CPB predicts AKI, so may identify patients in which intervention to improve renal oxygenation might reduce the risk of AKI.
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I N T R O D U C T I O N
Acute kidney injury (AKI) occurs in $30% of patients after cardiac surgery [1] . Even mild AKI after cardiopulmonary bypass (CPB) is associated with a >4-fold increase in risk of inhospital death [1] . In severe AKI, requiring renal replacement therapy (1-2% of patients after surgery on CPB), mortality exceeds 35% [2] . Available biomarkers [3] offer limited prediction of AKI at arrival in the intensive care unit (ICU) [4, 5] , but there are currently no biomarkers with predictive value during surgery, when intervention is still feasible. The etiology of AKI after cardiac surgery is complex [6, 7] . Nevertheless, hypoxia in the renal medulla appears to be a hallmark of AKI [8] , being present not just during and after experimental CPB [9] [10] [11] , but also in AKI induced by sepsis [12] , ischemia-reperfusion injury [13] , administration of radiocontrast agents [14] and rhabdomyolysis [15] . Additionally, renal oxygen delivery is impaired in humans on CPB [16] . Medullary hypoxia may thus represent a major driver of AKI.
It is not feasible to measure renal medullary oxygen tension (PO 2 ) in patients during cardiac surgery. However, it is feasible to measure continuously the PO 2 of bladder urine via a fiber optic probe placed in the bladder catheter [17, 18] . Bladder urine PO 2 correlates strongly with renal medullary PO 2 in sheep during hyperdynamic septic AKI [19, 20] and in rabbits during pharmacologically induced changes in medullary PO 2 [21] . Thus, we conducted a pilot study to test the hypothesis that urinary hypoxia during cardiac surgery requiring CPB predicts later development of AKI.
M A T E R I A L S A N D M E T H O D S

Observational protocol
The protocol was approved by the Human Research Ethics Committee of Monash Health (Reference: 12375B) and conformed to the Declaration of Helsinki. All patients provided informed consent. Between January 2015 and August 2017, 68 patients undergoing cardiac surgery requiring CPB were prospectively enrolled. Three patients were subsequently excluded, leaving a sample of 65 patients (Supplementary data, Figure S1 and Supplementary Methods). We included patients undergoing coronary artery bypass graft (CABG) surgery, valve repair/replacement surgery or combined 'CABG-valve' surgery. We excluded patients: with a baseline serum creatinine >200 lmol/L, or an estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m 2 ; on hemodialysis (acutely or long term); who were kidney transplant recipients; with preoperative (pre-op) AKI as defined by the Kidney Disease: Improving Global Outcomes (KDIGO) AKI criteria [22] ; or who were unable to provide informed consent. The sample of convenience was enriched with patients deemed at high risk of in-hospital death, based on their logistic EuroSCORE [23] . Many of the factors in the EuroSCORE are also risk factors for postoperative AKI [24] .
Anesthesia, surgery and perfusion
Standard institutional protocols were followed (Supplementary Methods).
Continuous measurement of urinary PO 2
The urinary bladder was catheterized with a standard Foley urinary catheter (Medtronic, Minneapolis, MN, USA). A sterilized fiber optic luminescence optode (NX-LAS-1/O/E-5 m, Oxford Optronix, Abingdon, UK) was advanced through the lumen of the catheter, to the catheter tip, so that the sensing tip of the probe was in direct contact with bladder urine. The bladder catheter was then connected to a standard urine collection system (see Supplementary Methods). Urinary PO 2 was measured at 6-s intervals during surgery. Other data available from patient monitoring systems were recorded every 5 min (see Supplementary Methods).
Definition of AKI
Serum creatinine concentration was assessed preoperatively, at the time of entry to the ICU, and then daily (between midnight and 5:00 am) thereafter until discharge. The primary outcome was postoperative AKI, defined by modified KDIGO criteria [22] , that is, a maximum increase in serum creatinine of !0.30 mg/dL (26.5 mmol/L) from pre-op baseline within the first 48 h after surgery, or !50% within the first 5 days after surgery. We did not utilize the urine output criterion for diagnosis of AKI, on the basis that it may result in over-diagnosis [25, 26] .
Statistical analysis
Continuous variables that satisfied the Shapiro-Wilk test are presented as mean 6 SD [27] . For variables that failed this test of normality, the data were plotted and if the distribution was skewed, data are presented as median (interquartile range) and nonparametric statistical tests were used. Statistical analyses were performed using SPSS (Version 23.0, IBM Corp., Armonk, NY, USA). Two-sided P 0.05 was considered statistically significant.
Dichotomous comparisons were made using Student's unpaired t-test or the Mann-Whitney U test. Differences in proportions were assessed using chi-square, or with Fisher's exact test when subgroups had fewer than five observations. P-values from within-subject factors in repeated measures analysis of variance were adjusted using the Greenhouse-Geisser method [28] .
Univariable logistic regression was used to identify associations between various thresholds of intraoperative urinary PO 2 and development of postoperative AKI. The sensitivity and specificity of each threshold was assessed using receiveroperator characteristic (ROC) curves. Factors with P 0.10 were then introduced into multivariable regression analyses. Model 1 included all variables with P 0.10 from univariable analysis. In multivariable Model 2, variables with P > 0.10 were removed step-wise until only those with P 0.10 remained. A similar approach was taken to assess factors associated with urinary hypoxia.
R E S U L T S
Patient and surgical characteristics
Of the 65 patients included in the analyses, 26 (40%) developed AKI (Table 1) .
Preoperatively, a greater proportion of patients who later developed AKI had hypertension, New York Heart Association (NYHA) Class !III heart failure or were undergoing a double or triple valve procedure (Table 1) . Patients who later developed AKI also had a 15% lower baseline eGFR and a greater pre-op risk of dialysis (Mehta Score). The median logistic EuroSCORE did not differ significantly between the two groups of patients.
Patients who developed AKI had operations that were 25% longer in duration than patients who did not develop AKI (Supplementary data, Table S1 ). The durations of CPB (149 6 88 versus 109 6 52 min) and aortic cross-clamp (111 6 63 versus 83 6 48 min) were also longer for patients who developed AKI. Patients who developed AKI were more often administered furosemide, received greater amounts of norepinephrine after CPB, had 0.6 L more positive net volume status and 4.8 mmHg lower nadir mean arterial pressure (MAP) than patients who did not develop AKI (Supplementary data, Table S2 ). Postoperatively, patients with AKI required a eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [29] . Risk scores are shown for (i) The European System for Cardiac Operative Risk Evaluation (Logistic EuroSCORE) [23] ; (ii) Mehta Score [24] ; and (iii) the Cleveland Clinic Score [30] , for prediction of risk of dialysis after cardiac surgery. Of the 26 patients who developed AKI, 15 had Stage 1 injury (increase in serum creatinine >26.5 lmol/L from baseline within 48 h, or >50% within 5 days); 7 had Stage 2 injury (increase in serum creatinine >100% within 5 days); and 4 patients developed Stage 3 injury (increase in serum creatinine >200% within 5 days or need for hemodialysis) [22] . Three patients required postoperative dialysis and were the only patients in the cohort of 65 who died in hospital. For the 26 patients who developed AKI, the diagnostic criterion was reached, on average, 20.6 6 14.8 h after admission to the ICU. longer periods of ventilation and ICU stay and more often required blood products than patients who did not develop AKI (Supplementary data, Table S1 ).
Intraoperative urinary PO 2
Urinary PO 2 progressively fell across the course of the surgical procedure ( Figure 1A and B). After induction of anesthesia and before the first incision (epoch 1; baseline), the mean urinary PO 2 was 65.5 6 34.5 mmHg. Mean urinary PO 2 then fell by 31% from pre-op levels, to 45.2 6 25.9 mmHg, during the period after the first incision and before going on CPB (epoch 2). It fell by a further 24% from baseline, to a mean of 29.3 6 19.5 mmHg during the first (mild hypothermic) phase of CPB. Mean urinary PO 2 continued to fall by a further 9% during the second (rewarming) phase of CPB, to 23.4 6 16.0 mmHg. Critically, even once patients were weaned from CPB, urinary PO 2 did not recover to pre-or early-bypass levels. Post-bypass, urinary PO 2 were on average less than half that of pre-bypass levels (23.5 6 14.9 mmHg versus 49.1 6 26.9 mmHg).
The overall profile of mean urinary PO 2 did not differ significantly between patients who developed AKI and those who did not (Figure 1 ). However, mean urinary PO 2 during the post-bypass epoch was lower in patients who later developed AKI (18.7 6 9.0 versus 26.7 6 17.2 mmHg, P ¼ 0.03). Furthermore, in patients who later developed AKI, the lowest level of urinary PO 2 during surgery (nadir) was 40% less than that of patients in the non-AKI group (8.9 6 5.6 versus FIGURE 1: Urinary oxygen tension during on-pump cardiac surgery. Urinary PO 2 was recorded continuously for 98.8% of the period of CPB and 98.5% of the total duration of surgery. For each individual patient, urinary PO 2 was averaged over time using all available measurements during each epoch. (A) Columns and error bars are mean 6 SD of urinary PO 2 during the five epochs of surgery. Pre-Op, the period after induction of anesthesia but before the first incision; Pre-CPB, the period of surgery prior to commencement of CPB; CPB-Hypothermic, hypothermic CPB; CPB-Rewarm, the period of rewarming on bypass; and Post-CPB, the period of surgery after weaning from CPB. P Group , P Epoch and P Group*Epoch are the outcomes of repeated measures analysis of variance. P-values above each pair of measurements are from Student's unpaired t-test. (B) Scatterplot showing the mean urinary PO 2 for each individual subject, across each epoch of surgery. Solid horizontal lines represent the between-subject mean urinary PO 2 . (C) The lowest level of urinary PO 2 (nadir) recorded during surgery for each subject. Error bars are mean 6 SD. The P-values are the outcomes of Student's unpaired t-test.
14.9 6 10.2 mmHg, P ¼ 0.008). In 72% of the 65 patients, intraoperative nadir urinary PO 2 occurred during the rewarming or post-bypass epochs. This pattern was similar in patients who later developed AKI (19 of 26, 73%) and those who did not (28 of 39, 72%).
Urinary hypoxia
We calculated the time spent at or below the threshold levels of urinary PO 2 of 15, 10 and 5 mmHg, as well as the area under the curve for these thresholds (Supplementary data, Figure S2 ). These variables are expressed as a function of the total duration of each surgical procedure to allow comparison between patients. Patients who later developed AKI experienced 11-fold longer periods of urinary PO 2 15 mmHg, and the area under the curve was 51-fold greater, than patients who did not later develop AKI ( Table 2 ). Periods of urinary PO 2 10 or 5 mmHg also tended to occur more commonly in patients who later developed AKI, but these periods were rare. Thus, we considered a threshold of 15 mmHg as useful working definition of urinary hypoxia.
Clinical parameters monitored across the entire surgical procedure Body temperature, MAP and saturation of arterial hemoglobin with oxygen (S A O 2 ) did not differ significantly between patients who later developed AKI and those who did not (Figure 2 ). Intraoperative urine flow increased dramatically during CPB. It was greatest during the rewarming phase, reaching 7.4 6 4.8 mL/min across all patients, before declining to 6.0 6 4.7 mL/min in the post-bypass period. Intraoperative urine flow was on an average 3.2 mL/min (37%) less during the rewarming phase and 3.0 mL/min (42%) less during the post-bypass period in patients who later developed AKI, than those who did not.
Hemodynamics and whole-body oxygenation during CPB
No differences in hemodynamic parameters of CPB were detected between patients who later developed AKI and those who did not (Table 3) .
Variables monitored only before and after CPB
When averaged over the periods before and after bypass, central venous pressure (CVP) was 2.8 6 0.9 mmHg greater, mean pulmonary artery pressure (PAP) was 3.5 6 2.2 mmHg greater and end-tidal PCO 2 was 2.1 6 0.8 mmHg less, in patients who developed AKI than in those who did not (Supplementary data, Table S3 ).
Intraoperative urinary hypoxia predicts AKI after cardiac surgery
In univariable analysis, the odds of developing AKI were 3.60-fold greater when intraoperative urinary PO 2 fell to 10 mmHg at any time during the surgical procedure (Figure 3 ; Supplementary data, Table S4 ). The duration of urinary PO 2 at or below specific thresholds, when expressed as continuous variables, were also associated with risk of AKI. For every minute per hour of surgery, urinary PO 2 was 15 mmHg, the risk of AKI was 4% greater, while it was 7% greater for a threshold of 10 mmHg. The median duration of urinary PO 2 Apart from urinary hypoxia, other factors associated with the development of AKI were: lower baseline eGFR, NYHA Class !III, lower intraoperative urine output, longer duration of CPB and surgery, higher average CVP and average mean PAP measured before and after CPB, administration of more norepinephrine in the post-bypass period, lower nadir MAP during surgery and greater net positive fluid balance at the conclusion of surgery (Table 4) . When these, and other variables with P 0.10 in univariable analysis, were included in a multivariable model, the area under the ROC curve was 0.89 (95% CI 0.81-0.97) (Model 1 in Table 4 ). In multivariable analysis with backward step-wise elimination (Model 2 in Table 4 ), only intraoperative urinary hypoxia ( 15 mmHg for !4.8 min/h), lower intraoperative urine output and a greater amount of norepinephrine administered post-bypass were found to be Values are median (Q1, Q3) or mean 6 SD. P-values were derived from the Mann-Whitney U test or Student's unpaired t-test. Urinary PO 2 fell to 15 mmHg in 47 patients (25 non-AKI, 22 AKI), to 10 mmHg in 29 patients (13 non-AKI and 16 AKI) and to 5 mmHg in 13 patients (5 non-AKI and 8 AKI). The area under the curve was determined by integrating the magnitude by which urinary PO 2 was less than or equal to each specific threshold by the time below the threshold (Supplementary Figure 2) . Both time at or below each threshold and the areas under the curve were normalized to the total duration of the surgery.
independently associated with later development of AKI. In this model, the odds ratio (OR) for urinary hypoxia was 7.48 (95% CI 1.54-36.43) and the area under the ROC curve was 0.87 (95% CI 0.78-0.96).
Factors associated with urinary hypoxia
Univariable analysis revealed significant associations of urinary hypoxia (urinary PO 2 15 mmHg for !4.8 min/h) with: longer durations of surgery and CPB, lesser blood hemoglobin concentration and oxygen delivery (DO 2 ) on bypass, intraoperative administration of furosemide and metaraminol, as well as the use of more epinephrine or norepinephrine in the post-bypass period (Table 5 ). Multivariable analysis revealed independent associations of urinary hypoxia with longer duration of surgery, lesser DO 2 on bypass and the use of norepinephrine. 
D I S C U S S I O N
Our major findings were: (i) it is feasible to continuously measure bladder urine PO 2 in the operating theater using a fiber optic probe; (ii) bladder urine PO 2 falls across the course of cardiac surgery, reaching its nadir most commonly during the rewarming phase of CPB or early after weaning from CPB; (iii) patients who develop AKI after cardiac surgery experience longer and more severe periods of low intraoperative urinary PO 2 than patients who do not develop AKI; and (iv) low intraoperative urinary PO 2 is an independent predictor of postoperative AKI. Thus, urinary PO 2 may provide the first available real-time 'biomarker' of risk of postoperative AKI in the setting of cardiac surgery that provides prognostic information during the surgical procedure itself, when it may not be too late to intervene to prevent AKI.
The detrimental impact of hypoxia could depend on both its duration and severity. Therefore, we calculated the time spent at or below various thresholds of urinary PO 2 (15, 10 and 5 mmHg) and the area under the curve for each threshold. At thresholds of 15 and 10 mmHg, the duration spent at or below the threshold and the area under the curve was much greater in patients who later developed AKI than in those who did not. Furthermore, univariable logistic regression showed that the odds of AKI were 3.6 times greater when urinary PO 2 fell to 10 mmHg at any time during the operation. This analysis provides insight into what we define as 'urinary hypoxia'; the severity and duration of low intraoperative urinary PO 2 that indicates increased risk of AKI. Our analysis suggests that a threshold of 15 mmHg may identify a level of risk that merits intervention. Univariable analyses were performed for variables found to differ significantly between patients who developed AKI and those who did not (Tables 1 and 2; Supplementary data,  Tables S1 and S2 ). The only exceptions to this were for the variables '>1 valve' and 'intraoperative furosemide', where logistic regression could not be performed due to 100% association with development of postoperative AKI. Univariable outcomes with P 0.10 were eligible for inclusion in the multivariable logistic regression models. Urine PO 2 and AKI in cardiac surgery 
Continued
Established risk factors for AKI after cardiac surgery include high baseline serum creatinine and/or impaired eGFR [31, 32] , heart failure [24, 30, 32] , longer duration of CPB [1, 32] , low pre-and intraoperative hemoglobin concentration [1] , low DO 2 during CPB [33, 34] and low intraoperative urine flow [31] . In multivariable logistic regression controlling for such factors with P 0.10 in univariable analysis, a strong independent association was found between AKI and intraoperative urinary hypoxia, as defined by urinary PO 2 15 mmHg for more than or equal to the median duration for all 65 patients (4.8 min/h of surgery). In backward step-wise multivariable logistic regression, only urinary hypoxia, low intraoperative urine flow and a greater amount of norepinephrine administered post-bypass were independently associated with AKI.
The predictive value of urinary hypoxia compares with those of current and emerging biomarkers of AKI. The area under the curve for urinary hypoxia established in the current study was 0.69. This is comparable to that achieved with available biomarkers of renal injury measured soon after weaning from CPB or within 24 h of surgery [35] . The only exception may be the product of urinary concentrations of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor-binding protein 7, for which an area under the ROC curve of 0.81 (95% CI 0.68-0.93) was recently reported [36] . Nevertheless, unlike urinary PO 2 , none of these biomarkers has predictive efficacy when measured intraoperatively, or provides real-time information during CPB that might allow improved management of renal health. It is also noteworthy that the predictive efficacy of urinary hypoxia can be significantly improved by inclusion of certain pre-op (hypertension, low baseline eGFR and NYHA Class !III) and intraoperative (urine flow) factors in the model.
A number of lines of evidence indicate that urinary hypoxia during cardiac surgery reflects hypoxia in the renal medulla, as detailed in a recent review [37] . Medullary hypoxia has been observed during and after CPB in experimental animals [9] [10] [11] and is predicted by simulations using computational models [38, 39] . There is also clinical evidence that renal oxygen delivery falls during CPB [16] and that postoperative AKI is associated with intraoperative desaturation of renal tissue [40] . There is strong evidence that bladder urine PO 2 provides a relatively noninvasive estimate of renal medullary PO 2 . In the human inner medulla, vascular bundles are distributed between clusters of collecting ducts, providing a pathway for oxygen diffusion between vasa recta and urine [41] . Leonhardt et al. showed more than 50 years ago that the PO 2 of urine in the human renal pelvis is in equilibrium with renal medullary tissue PO 2 [42] . Provided urine flow is relatively high, this 'signal' of medullary oxygenation appears to survive the journey from the pelvis to the bladder. This proposition is supported by recent experimental observations in sheep [19, 20] and rabbits [21] , showing strong correlations between renal medullary PO 2 and bladder urine PO 2 under a range of conditions, and simulations using computational models of oxygen diffusion across the ureteric wall [21, 39] . Critically, CPB is usually accompanied by brisk diuresis, so provides an excellent platform to test the utility of bladder urine PO 2 as an intraoperative 'physiological biomarker' of risk of AKI.
Several established risk factors for AKI after CPB were significantly associated with urinary hypoxia by univariable (duration of surgery, hemoglobin concentration and whole-body DO 2 during CPB and requirement for epinephrine and/or norepinephrine support after weaning from CPB) and multivariable logistic regression. Thus, urinary hypoxia might capture the combined effects of pre-and intraoperative factors that lead to medullary hypoxia during on-pump cardiac surgery.
Our current findings show that urinary hypoxia during cardiac surgery indicates increased risk of AKI. But how might we intervene to ameliorate this risk? There is little evidence that specific pharmacological or non-pharmacological interventions can have a major impact on the risk of AKI associated with cardiac surgery [43, 44] . Continuous measurement of urinary PO 2 might provide a translational pathway for investigating novel interventions to prevent AKI, since it can be deployed in both experimental animals, in which regional kidney perfusion and oxygenation can be directly monitored [19] [20] [21] , and in man.
Our current study is limited by a relatively small sample size at a single center. For example, the small sample size precludes a subanalysis in which we might exclude mild renal dysfunction (Stage 1), or employ newer statistical methods such as the net reclassification index [45] or integrated discrimination index [46] . However, strengths include the prospective design and the use of a fiber optic method for continuous measurement of urinary PO 2 that could feasibly be applied to routine clinical practice.
Our finding that urinary PO 2 progressively decreases after the start of CPB is consistent with previous clinical observations using polarographic electrodes [47] . In this previous study, post-CPB recovery of urinary PO 2 was associated with better postoperative renal function. Our current observations provide two major advances. First, we show that urinary hypoxia during surgery, rather than just post-CPB recovery of urinary PO 2 , predicts development of AKI. Secondly, the fiber optic probe we used avoids many of the limitations of polarographic electrodes such as fragility and the need for repeated calibration. Thus, the method we have used is feasible for routine clinical use and provides prognostic information during surgery, when it is still feasible to intervene to prevent AKI.
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